Seizure control with antiepileptic drug therapy in 517 consecutive adult outpatients at the Kork Epilepsy Centre
- PMID: 23274162
- DOI: 10.1684/epd.2012.0544
Seizure control with antiepileptic drug therapy in 517 consecutive adult outpatients at the Kork Epilepsy Centre
Abstract
In order to assess the efficacy of modern antiepileptic drug (AED) therapy, we collected data from 517 consecutive adult outpatients referred to our centre between March and August 2011. In total, 211 patients (40.8%) were treated with monotherapy, 208 patients (40.2%) with a combination of two AEDs, and for the remaining patients (n=98; 19%) more than two AEDs were combined. The most common AEDs were valproate, lamotrigine, carbamazepine, and levetiracetam. Of the recent AEDs, levetiracetam was the leading drug with regards to drug combinations. Freedom of seizures for more than one year was achieved in 291 patients (56.3%). Under monotherapy, 168 patients (32.5% of all patients; 79.6% of patients with monotherapy) became seizure-free. Seizure-freedom with two AEDs was achieved in 103 patients (19.9% of all patients; 49.5% of patients with two AEDs) and in 20 patients with three AEDs (3.9% of all patients; 25.3% of patients with three AEDs). We conclude from this cross-sectional survey in a large patient group that combinations may still lead to treatment success in a considerable proportion of patients.
Similar articles
-
Pharmacological outcomes in newly diagnosed epilepsy.Epilepsy Behav. 2005 May;6(3):382-7. doi: 10.1016/j.yebeh.2005.01.008. Epilepsy Behav. 2005. PMID: 15820347 Clinical Trial.
-
Evolving antiepileptic drug treatment in juvenile myoclonic epilepsy.Arch Neurol. 2003 Aug;60(8):1100-5. doi: 10.1001/archneur.60.8.1100. Arch Neurol. 2003. PMID: 12925366
-
Efficacy and tolerability of conversion to monotherapy with lamotrigine compared with valproate and carbamazepine in patients with epilepsy.Epilepsy Behav. 2004 Aug;5(4):532-8. doi: 10.1016/j.yebeh.2004.04.006. Epilepsy Behav. 2004. PMID: 15256191 Clinical Trial.
-
Preliminary efficacy of levetiracetam in monotherapy.Epileptic Disord. 2003 May;5 Suppl 1:S51-5. Epileptic Disord. 2003. PMID: 12915342 Review.
-
The first line of therapy in a girl with juvenile myoclonic epilepsy: should it be valproate or a new agent?Epilepsia. 2009 Sep;50 Suppl 8:16-20. doi: 10.1111/j.1528-1167.2009.02230.x. Epilepsia. 2009. PMID: 19702728 Review.
Cited by
-
Key steps and barriers in the journey of patients with epilepsy through the National Healthcare System in Spain: The EPIPASS qualitative study.Epilepsia Open. 2024 Oct;9(5):1731-1744. doi: 10.1002/epi4.12984. Epub 2024 Jul 4. Epilepsia Open. 2024. PMID: 38965814 Free PMC article.
-
Levetiracetam and brivaracetam: a review of evidence from clinical trials and clinical experience.Ther Adv Neurol Disord. 2019 Sep 9;12:1756286419873518. doi: 10.1177/1756286419873518. eCollection 2019. Ther Adv Neurol Disord. 2019. PMID: 31523280 Free PMC article. Review.
-
Early add-on lacosamide in a real-life setting: results of the REALLY study.Clin Drug Investig. 2015 Feb;35(2):121-31. doi: 10.1007/s40261-014-0255-5. Clin Drug Investig. 2015. PMID: 25488477
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical